High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.

Thirty-eight patients with previously treated Hodgkin's disease were given high dose combination chemotherapy using melphalan and BCNU and autologous bone marrow transplantation. In 25 patients etoposide was added in conventional dosage. During the course of the study the dose of melphalan was...

Full description

Saved in:
Bibliographic Details
Main Authors: Zulian, G. B., Selby, P., Milan, S., Nandi, A., Gore, M., Forgeson, G., Perren, T. J., McElwain, T. J.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 1989
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2247129/
https://ncbi.nlm.nih.gov/pubmed/2653400
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items